Mengyang Liu

Dr. Mengyang Liu

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
Mengyang LiuMengyang Liu
Mengyang Liu
Jingyuan WenJingyuan Wen
Jingyuan Wen
MSManisha Sharma
Manisha Sharma
Solid lipid nanoparticles (SLNs) have shown potential as a novel lipid-based drug delivery system for the topical applications of innumerable therapeutic compounds. However, the mechanisms governing the absorption and cellular uptake of SLNs through topical route, along with the mechanism of drug release from SLNs are still ambiguous, and require further investigation. In addition, the selection of an appropriate dosage form/formulation base is essential for ease of application of SLNs and to enhance dermal and transdermal delivery. Upscaling and regulatory approvals are other challenges that may impede the clinical translation of SLNs. Therefore, this review focusses on different mechanisms involved in skin penetration and cellular uptake of SLNs. This is followed by a comprehensive discussion on the physicochemical properties of SLNs including various formulation and dosage form factors, which might influence the absorption of SLNs through the skin. Finally, translational status with respect to scale-up and regulatory aspects are also discussed. This review will be useful to researchers with an interest in topical applications of SLNs for the efficient delivery of drugs and cosmetics.

22 March 2025 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
TGTianjiao Geng
Tianjiao Geng
LDLing Ding
Ling Ding
Mengyang LiuMengyang Liu
Mengyang Liu
XZXiaoyan Zou
Xiaoyan Zou
ZGZhichun Gu
Zhichun Gu
LSLihua Sun
Lihua Sun

2 January 2022 in Pharmaceutical Development and Technology
Verified
Journal Article
Closed access
Mengyang LiuMengyang Liu
Mengyang Liu
SCShuo Chen
Shuo Chen
ZZZhiwen Zhang
Zhiwen Zhang
HLHongyu Li
Hongyu Li
Guiju SunGuiju Sun
Guiju Sun
Jingyuan WenJingyuan Wen
Jingyuan Wen
Skin ageing is a cumulative result of oxidative stress, predominantly caused by reactive oxygen species (ROS). Respiration, pollutants, toxins, or ultraviolet A (UVA) irradiation produce ROS with 80% of skin damage attributed to UVA irradiation. Anti-ageing peptides and proteins are considered valuable compounds for removing ROS to prevent skin ageing and maintenance of skin health. In this review, skin ageing theory has been illustrated with a focus on the mechanism and relationship with anti-ageing peptides and proteins. The effects, classification, and transport pathways of anti-ageing peptides and proteins across skin are summarized and discussed. Over the last decade, several novel formulations and advanced strategies have been developed to overcome the challenges in the dermal delivery of proteins and peptides for skin ageing. This article also provides an in-depth review of the latest advancements in the dermal delivery of anti-ageing proteins and peptides. Based on these studies, this review prospected several semi-solid dosage forms to achieve topical applicability for anti-ageing peptides and proteins. Graphical Abstract

27 October 2020 in Journal of Drug Targeting
Verified
Journal Article
Closed access
DLDanhui Li
Danhui Li
NMNataly Dominica Martini
Nataly Dominica Martini
Mengyang LiuMengyang Liu
Mengyang Liu
JFJames Robert Falconer
James Robert Falconer
MLMichelle Barbara Locke
Michelle Barbara Locke
Jingyuan WenJingyuan Wen
Jingyuan Wen
Numerous skin disorders and diseases are related to oxidative stress. The application of an antioxidant, serving as a strong defense agent against oxidation, is of great interest in dermatology yet remains challenging for delivery. This paper aimed to develop a niosome carrier system to deliver the antioxidant C into the skin.C-loaded niosomes were prepared using film hydration technique and the physicochemical properties of the drug-loaded niosomes were characterized and investigated by a series of in vitro and ex vivo studies. The optimized formulation displayed an acceptable size in nanoscale (204 nm), high drug entrapment efficiency (49%) and amorphous state of drug in niosomes. It was found that C-loaded niosomes could effectively prolong the drug release. Drug deposition in the viable layers of human skin was significantly enhanced when niosome carriers were applied (p < 0.05). Compared to the pure drug, the niosome formulation had a greater protective effect on the human skin fibroblasts (Fbs). This is consistent with the observation of internalization of niosomes by Fbs which was concentration-, time- and temperature- dependent, via an energy dependent process of endocytosis. The research highlighted that niosomes are potential topical carriers for dermal delivery of antioxidants in skin-care and pharmaceutical products.

14 March 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Mengyang LiuMengyang Liu
Mengyang Liu
DSDarren Svirskis
Darren Svirskis
Thomas ProftThomas Proft
Thomas Proft
JLJacelyn Loh
Jacelyn Loh
YHYuan Huang
Yuan Huang
Jingyuan WenJingyuan Wen
Jingyuan Wen
Background: Although its immunomodulatory properties make thymopentin (TP5) appealing, its rapid metabolism and inactivation in the digestive system pose significant challenges for global scientists. PEGylated niosomal nanocarriers are hypothesized to improve the physicochemical stability of TP5, and to enhance its intestinal permeability for oral administration. Methods: TP5-loaded PEGylated niosomes were fabricated using the thin film hydration method. Co-cultured Caco-2 and HT29 cells with different ratios were screened as in vitro intestinal models. The cytotoxicity of TP5 and its formulations were evaluated using an MTT assay. The cellular uptake and transport studies were investigated in the absence or presence of variable inhibitors or enhancers, and their mechanisms were explored. Results and Discussion: All TP5 solutions and their niosomal formulations were nontoxic to Caco-2 and HT-29 cells. The uptake of TP5-PEG-niosomes by cells relied on active endocytosis, exhibiting dependence on time, energy, and concentration, which has the potential to significantly enhance its cellular uptake compared to TP5 in solution. Nevertheless, cellular transport rates were similar between TP5 in solution and its niosomal groups. The cellular transport of TP5 in solution was carried out mainly through MRP5 endocytosis and a passive pathway and effluxed by MRP5 transporters, while that of TP5-niosomes and TP5-PEG-niosomes was carried out through adsorptive- and clathrin-mediated endocytosis requiring energy. The permeability and transport rate was further enhanced when EDTA and sodium taurocholate were used as the penetration enhancers. Conclusions: This research has illustrated that PEG-niosomes were able to enhance the cellular uptake and maintain the cellular transport of TP5. This study also shows this formulation’s potential to serve as an effective carrier for improving the oral delivery of peptides.

24 December 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Mengyang LiuMengyang Liu
Mengyang Liu
MSManisha Sharma
Manisha Sharma
GLGuo-Liang (Leon) Lu
Guo-Liang (Leon) Lu
ZZZhiwen Zhang
Zhiwen Zhang
WSWenting Song
Wenting Song
Jingyuan WenJingyuan Wen
Jingyuan Wen
Background: Skin ageing, driven predominantly by oxidative stress from reactive oxygen species (ROS) induced by environmental factors like ultraviolet A (UVA) radiation, accounts for approximately 80% of extrinsic skin damage. L-glutathione (GSH), a potent antioxidant, holds promise in combating UVA-induced oxidative stress. However, its instability and limited penetration through the stratum corneum hinder its topical application. This study introduces a novel solid lipid nanoparticle (SLN)-enriched hydrogel designed to enhance GSH stability, skin penetration, and sustained release for anti-ageing applications. Methods: GSH-loaded SLNs were prepared via a double-emulsion technique and optimized using factorial design. These SLNs were incorporated into 1–3% (w/v) Carbopol hydrogels to produce a semi-solid formulation. The hydrogel’s characteristics, including morphology, mechanical and rheological properties, drug release, stability, antioxidant activity, cytotoxicity, and skin penetration, were evaluated. Results: SEM and FTIR confirmed the uniform dispersion of SLNs within the hydrogel. The formulation exhibited desirable properties, including gel strength (5.1 ± 0.5 g), spreadability (33.6 ± 1.9 g·s), pseudoplasticity, and elasticity. In vitro studies revealed a biphasic GSH release profile, with sustained release over 72 h and over 70% cumulative release. The hydrogel significantly improved antioxidant capacity, protecting human fibroblasts from UVA-induced oxidative stress and enhancing cell viability. Stability studies indicated that 4 °C was optimal for storage over three months. Notably, the hydrogel enhanced GSH penetration through the stratum corneum by 3.7-fold. Conclusions: This SLN-enriched hydrogel effectively improves GSH topical delivery and antioxidant efficacy, providing a promising platform for anti-ageing and other bioactive compounds with similar delivery challenges.